Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
July earnings matter, but long-term growth matters more.
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
Overview
Abbott Laboratories (NYSE: ABT) reports second-quarter earnings on July 16, and some investors are trying to determine whether to buy the stock before the report is released or wait for the results.
But you can't make a proper determination about this without first understanding what drives Abbot's growth. So let's take a closer look.
Details
Unlike some healthcare companies that depend heavily on a single blockbuster product, Abbott operates across four major business segments: medical devices, diagnostics, nutrition, and established pharmaceuticals. That diversification has helped the company remain resilient through changing healthcare and economic environments for nearly 50 years.
Source
Originally published at www.fool.com.
